organization

TARSIER PHARMA LTD

  • Country: Israel
  • project . 2019 - 2021
    Funder: EC Project Code: 879598
    Overall Budget: 3,461,500 EURFunder Contribution: 2,423,050 EUR
    Open Access mandate for Publications
    Partners: TARSIER PHARMA LTD

    Ocular inflammatory diseases – affecting hundreds of millions of people worldwide – impose a significant medical and economic burden on society and can lead to blindness. Today, corticosteroids are the most common method used to treat ocular non-infectious inflammation ...

Any information missing or wrong?Report an Issue